If a patient has had 2 appropriately administered doses of measles-mumps-rubella (MMR) vaccine and has a nonimmune response on a rubella titer (required in all pregnant women in Louisiana), should another dose of MMR vaccine be given? Is there any evidence that this would provide immunity to rubella?
If a patient has had 2 appropriately administered doses of measles-mumps-rubella (MMR) vaccine and has a nonimmune response on a rubella titer (required in all pregnant women in Louisiana), should another dose of MMR vaccine be given? Is there any evidence that this would provide immunity to rubella?
- Robert P. Blereau, MD
Morgan City, La
The Advisory Committee on Immunization Practices (ACIP) does not recommend more than 2 doses of MMR vaccine for anyone. In fact, the ACIP defines rubella immunity as either a positive serologic test result or one documented dose of rubella vaccine on or after the first birthday. Seroconversion following a single dose of rubella vaccine is 95%. Seroconversion after 2 doses is greater than 99%. The likelihood of a person's truly being susceptible after 2 doses of MMR vaccine is very remote, and the negative serologic result you report is most likely a false-negative. We encounter this issue frequently with commercial screening tests.
To my knowledge, there are no data on the administration of more than 2 doses of MMR. I suggest you do nothing. If you must take action on this for some programmatic reason (a school requirement, for instance), then in my opinion, you can give another dose. This will not be harmful, since the person is already immune. However, I do not recommend further serologic testing in such a patient.
- William L. Atkinson, MD, MPH
National Immunization Program
Centers for Disease Control
and Prevention
Atlanta
3 Reasons Urology Practices Should Add Onsite UTI PCR Labs Under New LCD Rules
March 11th 20251. ONSITE PCR TESTING BRINGS SIGNIFICANT CLINICAL BENEFITS TO A PRACTICE. - ACCURACY Traditional urine cultures can give false-negative results. - SPECIFICITY Accurate microbial identification leads to targeted treatment. - SPEED Same day results vs. 3-5 days for traditional urine cultures - - - ANTIBIOTIC RESISTANCE MARKERS Improves antimicrobial stewardship 2. MAINTAIN INDEPENDENCE BY INCREASING REVENUE SIGNIFICANTLY THROUGH REVENUE SHIFTING FROM THE REFERENCE LAB TO THE PRACTICE. - Turnkey: Consultation on COLA and CLIA certification, all necessary equipment, standard operating procedures, personnel sourcing and interview, billing and coding training, 3-4 days of onsite training. - Stark Law Compliant: Complies with anti-kickback statutes. - Medicare part B pays at 100%, Med Advantage Plans at 80% - No lab build-out, only 8 linear feet of counter space needed - Z-code procurement for required states 3. BETTER PATIENT CARE LEADS TO BETTER OUTCOMES. - CONVENIENCE Point of care, no third-party referral lab. - TIMELY Results early in the care process. - CORRECT MEDICATION Avoids two trips to the pharmacy. - BETTER OUTCOMES Reduction of recurrent UTI and hospitalizations